Sponsored Content | Webinar | Proton Therapy| October 13, 2016

WEBINAR: Economics of Establishing a Proton Therapy Center

This webinar is sponsored by IBA

IBA, proton therapy, economics of proton therapy, ROI of proton therapy, Proteus One

The webinar "Economics of Establishing a Proton Therapy Center," will help educate hospitals and oncology centers about the economics of building a proton therapy center and how it can potentially expand oncology services. IBA will take the mystery out of establishing a proton therapy center by walking attendees through the cost, staff, ROI and reimbursement management for a proton therapy center.

The webinar takes place Thursday, Nov. 3, 2016, 2-3 p.m. Eastern Time

Register for this webinar

 

Speakers

Joy Godby, BA, ROCC
Associate Director for Radiation Oncology
University of Texas MD Anderson Cancer Center
Houston, Texas

Godby manages the entire revenue cycle for radiation oncology (billing, coding, patient access, financial counseling, upfront appeals and back end appeals for all modalities). Her talk "Managing the Maze of Insurance authorization for Radiation Therapy" includes insights to reimbursement for oncology services.

 

Robert McElearney MBA
Vice President Strategic Accounts
IBA Proton Therapy North America

McElearney’s background in healthcare spans almost 20 years, working in every part of the country in senior positions of leadership in the healthcare industry. He led business development for the nation’s largest provider of mobile imaging services, directing its effort to expand into new business areas. McElearney provides overall new business leadership for IBA Inc. in partnering with health facilitates in developing a Proton Therapy Center.

 

Mary Elizabeth (Beth) Klein,
President, IBA Proton Therapy North America

Klein joined IBA in 2009, after more than 25 years with GE Healthcare. There she held various leadership roles including leading the nuclear medicine business and was the Americas commercial executive at TomoTherapy 2005-2007.

 

About IBA

IBA (Ion Beam Applications S.A.) is a global medical technology company focused on bringing integrated and innovative solutions for the diagnosis and treatment of cancer.s. The company is the worldwide technology leader in the field of proton therapy, which is considered to be the most advanced form of radiation therapy available today. IBA’s proton therapy solutions are flexible and adaptable, allowing customers to choose from universal full-scale proton therapy centers as well as compact, single-room systems. In addition, IBA also has a radiation dosimetry business and develops particle accelerators for the medical world and industry.

Headquartered in Belgium and employing about 1300 people worldwide, IBA has installed systems across the world. IBA is listed on the Pan-European stock exchange NYSE EURONEXT. (IBA: Reuters IBAB.BR and Bloomberg IBAB.BB) More information can be found at: www.iba-worldwide.com

 

Register for this webinar

Related Content

Elekta and Brainlab Offer Streamlined Workflow for Stereotactic Radiotherapy
News | Radiation Therapy | October 16, 2017
Elekta and Brainlab have reconfirmed their alliance for the integrated use of the Elekta Versa HD linear accelerator...
National Breast Center Founder Names Top Three Innovations in Breast Cancer Treatment
News | Women's Health | October 11, 2017
In 2017, invasive breast cancer will be diagnosed in about 252,710 women and 2,470 men in the U.S. and remains the...
CyberKnife System Provides Excellent Long-Term Control of Low-Risk Prostate Cancer
News | Stereotactic Body Radiation Therapy (SBRT) | October 10, 2017
Accuray Inc. announced that data from a prospective study of 230 men with low-risk prostate cancer showed 98.4 percent...
News | Image Guided Radiation Therapy (IGRT) | October 10, 2017
Elekta announced that members of the Elekta MR-linac Consortium reported data related to the advancement of the company...
Sponsored Content | Videos | Radiation Therapy | October 09, 2017
Benjamin Movsas, M.D., chair of the American Society for Radiation Oncology (ASTRO) Scientific Committee, explains ho
Sponsored Content | Videos | Radiation Therapy | October 09, 2017
David Beyer, M.D., chairman of the board for the American Society of Radiation Oncology (ASTRO), discusses the key th
News | Brachytherapy Systems | October 05, 2017
External researchers presented new clinical data supporting the use of iCAD’s Xoft Axxent Electronic Brachytherapy (eBx...
MedLever Showcases Radiation Oncology Applications at ASTRO 2017
News | Radiation Therapy | October 05, 2017
MedLever demonstrated its flagship platform and applications that simplify clinical workflow, enable interoperability,...
Majority of Recurrent Prostate Cancer Patients' Treatment Plan Changed Following Fluciclovine 18F PET/CT
News | Prostate Cancer | October 04, 2017
Blue Earth Diagnostics recently announced the results of a pre-planned interim analysis from an investigational...
International Trial Confirms Safety, Effectiveness of High-Dose Brachytherapy Plus Pelvic Radiation for Cervical Cancer
News | Brachytherapy Systems, Women's Healthcare | October 04, 2017
Findings from a new multicenter, international clinical trial confirm the effectiveness of high-dose brachytherapy or...
Overlay Init